查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1743721

骨科生物學市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、應用、最終用戶、地區和競爭細分，2020-2030 年

Orthobiologics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球骨科生物製品市場規模達58.9億美元，預計將穩定成長，到2030年複合年成長率達5.10%。骨科生物製品是醫療保健產業至關重要且不斷發展的領域，其核心在於應用生物材料（包括生長因子、幹細胞和生物材料）來促進骨骼、軟骨、肌腱和韌帶的癒合和再生。這些生物衍生療法廣泛應用於骨科手術、運動醫學和創傷護理，以增強人體的自然修復機制。生物技術的進步加速了新型骨科生物製品解決方案的開發，例如富血小板血漿 (PRP)、骨移植和合成替代品。包括美國骨科醫師學會 (AAOS) 頒發的2025年阿諾德·I·卡普蘭骨科生物製品傑出研究獎在內的行業認可，凸顯了該領域創新的重要性。隨著對微創和再生治療的需求不斷成長，骨科生物學市場將持續向全球擴張。

市場概覽
預測期 2026-2030
2024年市場規模 58.9億美元
2030年市場規模 78.7億美元
2025-2030 年複合年成長率 5.10%
成長最快的領域 醫院
最大的市場 北美洲

關鍵市場促進因素

人口老化

主要市場挑戰

缺乏長期數據

主要市場趨勢

幹細胞療法

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球骨科生物製劑市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（黏彈性補充產品、去礦骨基質、合成骨科生物製品、骨形態發生蛋白、同種異體移植等）
    • 依應用（骨關節炎和退化性關節炎、脊椎融合、軟組織損傷等）
    • 按最終使用者（醫院、骨科診所、門診護理中心、學術和研究機構以及牙科診所和設施）
    • 按地區（北美、歐洲、亞太、南美、中東和非洲）
    • 按公司分類（2024）
  • 產品市場圖
    • 按產品
    • 按應用
    • 按最終用戶
    • 按地區

第6章：北美骨科生物製品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲骨科生物製品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區骨科生物製品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲

第9章：南美洲骨科生物製品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲骨科生物製品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購
  • 產品開發
  • 最新動態

第 13 章：波特的分析

第 14 章：PESTEL 分析

第 15 章：競爭格局

  • Sanofi SA
  • Stryker Corporation
  • Zimmer Biomet
  • Seaspine Holdings Corporation
  • Medtronic PLC
  • DePuy Synthes
  • Bioventrus
  • Globus Medical
  • Arthrex Limited
  • Orthofix International

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16209

The Global Orthobiologics Market was valued at USD 5.89 billion in 2024 and is projected to grow steadily, registering a CAGR of 5.10% through 2030. Orthobiologics represent a vital and expanding area of the healthcare industry, centered on the application of biological materials-including growth factors, stem cells, and biomaterials-to facilitate the healing and regeneration of bones, cartilage, tendons, and ligaments. These biologically derived treatments are widely used in orthopedic surgery, sports medicine, and trauma care to enhance the body's natural repair mechanisms. Advances in biotechnology have accelerated the development of novel orthobiologic solutions such as platelet-rich plasma (PRP), bone grafts, and synthetic alternatives. Industry recognition, including the 2025 Arnold I. Caplan Award for Distinguished Research in Orthobiologics by AAOS, emphasizes the significance of innovation in this space. As demand rises for minimally invasive and regenerative treatments, the orthobiologics market is positioned for consistent global expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.89 Billion
Market Size 2030USD 7.87 Billion
CAGR 2025-20305.10%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Key Market Drivers

Aging Population

The aging global population is a key contributor to the rising demand in the orthobiologics market. With population forecasts by the World Population Prospects 2024 projecting a peak of 10.3 billion by the mid-2080s, the proportion of elderly individuals is set to rise significantly. Aging individuals are increasingly affected by musculoskeletal conditions such as osteoarthritis, joint degeneration, and fractures. These ailments drive demand for less invasive and regenerative treatments, with orthobiologic products like PRP and stem cell therapies emerging as preferred options. Older patients often seek therapeutic solutions that can relieve pain, promote tissue healing, and improve mobility without undergoing major surgery, fueling the market's growth trajectory.

Key Market Challenges

Lack of Long-Term Data

A major limitation in the orthobiologics space is the scarcity of long-term clinical data regarding the safety and efficacy of these treatments. While short-term outcomes have been promising, there is limited evidence on the durability of results, the need for retreatment, and potential long-term complications. This lack of comprehensive follow-up data can cause hesitation among clinicians and patients, slowing widespread adoption. Additionally, the absence of standardized treatment protocols restricts integration into routine clinical practice. Greater investment in long-term studies, post-market surveillance, and real-world evidence is essential to strengthen clinical confidence and support regulatory decision-making.

Key Market Trends

Stem Cell Therapies

Stem cell therapies are gaining traction as a transformative trend in orthobiologics, offering innovative regenerative options for orthopedic care. These therapies utilize either autologous or allogeneic stem cells to restore damaged musculoskeletal tissues. Applications include treatment for osteoarthritis, bone injuries, and cartilage defects. Autologous treatments like bone marrow aspirate concentrate (BMAC) and adipose-derived stem cells capitalize on the body's innate healing ability, while allogeneic options provide ready-to-use therapeutic alternatives. As biotechnology advances, enhanced techniques in cell processing and culture are driving the precision and effectiveness of these treatments. Despite the promise, regulatory challenges and the need for long-term clinical validation remain central to the responsible integration of stem cell-based therapies in mainstream orthopedic care.

Key Market Players

  • Sanofi SA
  • Stryker Corporation
  • Zimmer Biomet
  • Seaspine Holdings Corporation
  • Medtronic PLC
  • DePuy Synthes
  • Bioventrus
  • Globus Medical
  • Arthrex Limited
  • Orthofix International

Report Scope:

In this report, the Global Orthobiologics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Orthobiologics Market, By Product:

  • Viscosupplementation Products
  • Demineralized Bone Matrices
  • Synthetic Orthobiologics
  • Bone Morphogenic Protein
  • Allografts
  • Others

Orthobiologics Market, By Application:

  • Osteoarthritis and Degenerative Arthritis
  • Spinal Fusion
  • Soft-tissue Injuries
  • Others

Orthobiologics Market, By End User:

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Care Centers
  • Academic and Research Institutes
  • Dental Clinics and Facilities

Orthobiologics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Orthobiologics Market.

Available Customizations:

Global Orthobiologics Market report with the given Market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Types
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Orthobiologics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, and Others)
    • 5.2.2. By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-tissue Injuries, and Others)
    • 5.2.3. By End User (Hospitals, Orthopedic Clinics, and Ambulatory Care Centers, Academic and Research Institutes, and Dental Clinics and Facilities)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Orthobiologics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Orthobiologics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Orthobiologics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Orthobiologics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Orthobiologics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Orthobiologics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Orthobiologics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Orthobiologics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Orthobiologics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Orthobiologics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
      • 7.3.5.3. By Product
      • 7.3.5.4. By Application
      • 7.3.5.5. By End User

8. Asia-Pacific Orthobiologics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Orthobiologics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Orthobiologics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. India Orthobiologics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Orthobiologics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Orthobiologics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Orthobiologics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Orthobiologics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Orthobiologics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Orthobiologics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Orthobiologics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Orthobiologics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Orthobiologics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Orthobiologics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition
  • 12.2. Product Development
  • 12.3. Recent Developments

13. Porter's analysis

14. PESTEL analysis

15. Competitive Landscape

  • 15.1. Sanofi SA
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
  • 15.2. Stryker Corporation
  • 15.3. Zimmer Biomet
  • 15.4. Seaspine Holdings Corporation
  • 15.5. Medtronic PLC
  • 15.6. DePuy Synthes
  • 15.7. Bioventrus
  • 15.8. Globus Medical
  • 15.9. Arthrex Limited
  • 15.10. Orthofix International

16. Strategic Recommendations

17. About Us & Disclaimer